Video Experimental Relacionado

Updated: May 5, 2026

Three-dimensional Navigation-guided, Prone, Single-position, Lateral Lumbar Interbody Fusion Technique

Three-dimensional Navigation-guided, Prone, Single-position, Lateral Lumbar Interbody Fusion Technique

Published on: July 15, 2021

Uso de agonistas de los receptores GLP-1 y resultados perioperatorios después de ACDF: un estudio de cohorte de

Kevin Y Heo¹, Stephen R Barchick¹, Aubrie M Sowa¹

¹Department of Orthopaedic Surgery, Emory University School of Medicine, 21 Ortho Ln, Atlanta, Georgia, 30329.

The spine journal : official journal of the North American Spine Society

|January 2, 2026

Resumen

No abstract available in PubMed .

Palabras clave:

Discectomía y fusión cervical anterior Agonista de los receptores GLP-1 Agonista de los receptores de péptidos tipo glucagón Obesidad Complicaciones médicas postoperatorias Complicaciones quirúrgicas postoperatorias Diabetes mellitus de tipo 2

Más Videos Relacionados

Clinical Application of Microscope-Assisted Minimally Invasive Anterior Lumbar Interbody Fusion

Clinical Application of Microscope-Assisted Minimally Invasive Anterior Lumbar Interbody Fusion

Published on: June 16, 2023

Multilevel Oblique Lumbar Interbody Fusion in Degenerative Lumbar Disc Disease with Instability

Multilevel Oblique Lumbar Interbody Fusion in Degenerative Lumbar Disc Disease with Instability

Published on: July 25, 2025

Videos de Conceptos Relacionados

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...